1) A gov’t grant ~$5 million 2) Technology transfer for manufacturing and production by Fraunhofer. 3) Mainz colorectal trial with MRK if it took place.
The only time they got money was a government grant. Otherwise they were spending cash. Seems like a bunch of nothing for the delay.
All I know is the UK specials business would give a market cap higher. Still cheap for me. If this turns out to be desired for all solid tumors, the crazy numbers put out here will be small.